Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240
Latest Information Update: 21 Sep 2022
Price :
$35 *
At a glance
- Drugs Florquinitau F18 (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Diagnostic use
- 16 Sep 2022 Status changed from recruiting to completed.
- 04 Aug 2021 Planned End Date changed from 20 Aug 2021 to 20 Aug 2022.
- 04 Aug 2021 Planned primary completion date changed from 20 Aug 2021 to 20 Aug 2022.